These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5010684)

  • 1. The effect of phenobarbital or 2-diethylaminoethyl-2,2-diphenylvalerate on the activation of cyclophosphamide in vivo.
    Field RB; Gang M; Kline I; Venditti JM; Waravdekar VS
    J Pharmacol Exp Ther; 1972 Feb; 180(2):475-83. PubMed ID: 5010684
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of microsomal enzyme modifiers on toxicity and therapeutic activity of cyclophosphamide in mice.
    Hart LG; Adamson RH
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):391-401. PubMed ID: 5348409
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of dosage, phenobarbital, and 2-diethylaminoethyl-2,2-diphenylvalerate on the binding of cyclophosphamide and-or its metabolites to the DNA, RNA, and protein of the embryo and liver in pregnant mice.
    Murthy VV; Becker BA; Steele WJ
    Cancer Res; 1973 Apr; 33(4):664-70. PubMed ID: 4696467
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of phenobarbital and SKF 525A on the toxicity, elimination and metabolism of cyclophosphamide in newborn mice.
    Bus JS; Short RD; Gibson JE
    J Pharmacol Exp Ther; 1973 Mar; 184(3):749-56. PubMed ID: 4687235
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of phenobarbital on cyclophosphamide antitumor activity.
    Alberts DS; van Daalen Wetters T
    Cancer Res; 1976 Aug; 36(8):2785-9. PubMed ID: 1277188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A biochemical and pharmacological study of therapeutic synergism with 5-fluorouracil plus cyclophosphamide in murine L1210 leukemia.
    Fernandes DJ; Klubes P
    Cancer Res; 1979 Apr; 39(4):1396-404. PubMed ID: 421224
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of phenobarbital and SKF 525A on placental transfer of cyclophosphamide in mice.
    Gibson JE; Becker BA
    J Pharmacol Exp Ther; 1971 Apr; 177(1):256-62. PubMed ID: 5566767
    [No Abstract]   [Full Text] [Related]  

  • 8. Alterations in the toxicity and antitumor activity of methyl-CCNU in mice following pretreatment with either phenobarbital or SKF 525A.
    Klubes P; Miller HG; Cerna I; Trevithick J
    Cancer Treat Rep; 1979; 63(11-12):1901-7. PubMed ID: 526922
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of phenobarbital and SKF 525-A on the teratogenicity of cyclophosphamide in mice.
    Gibson JE; Becker BA
    Teratology; 1968 Nov; 1(4):393-8. PubMed ID: 4992685
    [No Abstract]   [Full Text] [Related]  

  • 10. Antileukemic synergism between cyclophosphamide and an antitumor platinum compound.
    Walker EM; Gale GR
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):419-25. PubMed ID: 4750093
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim.
    Stoychkov JN; Milushev AS; Todorov DK
    Neoplasma; 1980; 27(1):33-6. PubMed ID: 6892839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic metabolism of cyclophosphamide and nicotine and production of a toxic cyclophosphamide metabolite.
    Hill DL; Laster WR; Struck RF
    Cancer Res; 1972 Apr; 32(4):658-65. PubMed ID: 5014778
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of phenobarbital and SKF 525-A on the in vivo metabolism of morphine in rats.
    Liu SJ; Wang RI
    Drug Metab Dispos; 1980; 8(4):260-4. PubMed ID: 6105061
    [No Abstract]   [Full Text] [Related]  

  • 14. Different effects of pretreatment with 2-diethylaminoethyl-2,2-diphenylvalerate on the mouse liver polysomal disaggregation by dimethylnitrosamine and lasiocarpine.
    Garry VF; Lopez-Corella E; Plapp FV; Chiga M
    Res Commun Chem Pathol Pharmacol; 1972 Jan; 3(1):117-22. PubMed ID: 5030700
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
    Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
    Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.
    Burns ER; Scheving LE
    Chronobiologia; 1980; 7(1):41-51. PubMed ID: 7438892
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A.
    Cohen MH; Carbone PP
    J Natl Cancer Inst; 1972 Apr; 48(4):921-6. PubMed ID: 5023689
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine aggregation effect in mice under conditions of altered microsomal enzymes.
    Prabhu VG
    Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):81-6. PubMed ID: 5010835
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of drug metabolism. IV. Induction of drug metabolism by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and 2,4-dichloro-6-phenylphenoxyethylamine HBr (Lilly 18947) and the effect of induction on the inhibitory properties of SKF 525-A type compounds.
    Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):341-6. PubMed ID: 5968074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.